STOCK ALERT: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors of Important Deadline in Class Action
January 22 2016 - 11:58AM
Business Wire
Rosen Law Firm, a global investor rights law firm, reminds
purchasers of Esperion Therapeutics, Inc. (NASDAQ: ESPR) securities
from August 18, 2015 through September 28, 2015, both dates
inclusive (the “Class Period”) of the important March 14, 2016 lead
plaintiff deadline in the class action. The lawsuit seeks to
recover damages for Esperion Therapeutics investors under the
federal securities laws.
To join the Esperion Therapeutics class action, go to the firm’s
website at http://rosenlegal.com/cases-814.html or call Phillip
Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email
pkim@rosenlegal.com or kchan@rosenlegal.com for information on the
class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period,
Defendants issued materially false and misleading statements to
investors and/or failed to disclose that there was no clear path to
approval for ETC-1002, the FDA had encouraged Esperion Therapeutics
to initiate a cardiovascular outcomes trial (“CVOT”) and completion
of a CVOT could be necessary prior to approval of ETC-1002. When
the true details entered the market, the lawsuit claims that
investors suffered damages.
A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than
March 14, 2016. A lead plaintiff is a representative party acting
on behalf of other class members in directing the litigation. If
you wish to join the litigation, go to the firm’s website at
http://rosenlegal.com/cases-814.html or to discuss your rights or
interests regarding this class action, please contact Phillip Kim,
Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at
866-767-3653 or via e-mail at pkim@rosenlegal.com or
kchan@rosenlegal.com.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation. Attorney Advertising. Prior
results do not guarantee a similar outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160122005778/en/
The Rosen Law Firm, P.A.Laurence Rosen, Esq.Phillip Kim,
Esq.Kevin Chan, Esq.275 Madison Avenue, 34th FloorNew York, NY
10016Tel: 212-686-1060Toll Free: 866-767-3653Fax:
212-202-3827lrosen@rosenlegal.compkim@rosenlegal.comkchan@rosenlegal.comwww.rosenlegal.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024